المؤلفون: Coerver, E., Schoof, L., Hogenboom, L., Wessels, M., van Ruyven, P., van Samkar, A., Mostert, J., van Kempen, Z., van Oosten, B.W., Wokke, B.H., Tallantyre, E., Myhr, KM., Torkildsen, O., Killestein, J., Smets, I., Strijbis, E.

وصف الملف: application/pdf

Relation: https://orca.cardiff.ac.uk/id/eprint/172751/1/PIIS2211034824004760.pdf; Coerver, E., Schoof, L., Hogenboom, L., Wessels, M., van Ruyven, P., van Samkar, A., Mostert, J., van Kempen, Z., van Oosten, B.W., Wokke, B.H., Tallantyre, E. https://orca.cardiff.ac.uk/view/cardiffauthors/A466853R.html orcid:0000-0002-3760-6634 orcid:0000-0002-3760-6634, Myhr, KM., Torkildsen, O., Killestein, J., Smets, I. and Strijbis, E. 2024. The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis. Multiple Sclerosis and Related Disorders 91 , 105900. 10.1016/j.msard.2024.105900 https://doi.org/10.1016/j.msard.2024.105900 file https://orca.cardiff.ac.uk/id/eprint/172751/1/PIIS2211034824004760.pdf

الاتاحة: https://orca.cardiff.ac.uk/id/eprint/172751/
https://doi.org/10.1016/j.msard.2024.105900
https://orca.cardiff.ac.uk/id/eprint/172751/1/PIIS2211034824004760.pdf

المؤلفون: Toorop, A A, Wessels, M H J, Gelissen, L M Y, Hoitsma, E, Zeinstra, E M P E, van Rooij, L C, van Munster, C E P, Vennegoor, A, Mostert, J P, Wokke, B H A, Kalkers, N F, Hoogervorst, E L J, van Eijk, J J J, Roosendaal, C M, Kragt, J J, Eurelings, M, van Genugten, J, Nielsen, J, Sinnige, L G F, Kloosterziel, M E, Arnoldus, E P J, van Dijk, G W, Bouvy, W H, Strijbis, E M M, van Oosten, B W, de Jong, B A, Lissenberg-Witte, B I, Rispens, T, Uitdehaag, B M J, Killestein, J, van Kempen, Z L E

المصدر: Toorop , A A , Wessels , M H J , Gelissen , L M Y , Hoitsma , E , Zeinstra , E M P E , van Rooij , L C , van Munster , C E P , Vennegoor , A , Mostert , J P , Wokke , B H A , Kalkers , N F , Hoogervorst , E L J , van Eijk , J J J , Roosendaal , C M , Kragt , J J , Eurelings , M , van Genugten , J , Nielsen , J , Sinnige , ....

الاتاحة: https://research.vumc.nl/en/publications/495a7fab-dbbe-44df-9cb7-9a4c360d4cfe
https://doi.org/10.1016/j.jns.2024.123102
http://www.scopus.com/inward/record.url?scp=85196715940&partnerID=8YFLogxK

المؤلفون: Noteboom, S., Strijbis, E. M.M., Coerver, E. M.E., Colato, E., van Kempen, Z. L.E., Jasperse, B., Vrenken, H., Killestein, J., Schoonheim, M. M., Steenwijk, M. D.

المصدر: Noteboom , S , Strijbis , E M M , Coerver , E M E , Colato , E , van Kempen , Z L E , Jasperse , B , Vrenken , H , Killestein , J , Schoonheim , M M & Steenwijk , M D 2024 , ' Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis : Evidence from real-world clinical data ' , Multiple Sclerosis and Related Disorders , vol. 87 , 105670 . https://doi.org/10.1016/j.msard.2024.105670

الاتاحة: https://research.vumc.nl/en/publications/8fd8dc95-92d2-4195-ba9a-db48b23b4c8f
https://doi.org/10.1016/j.msard.2024.105670
http://www.scopus.com/inward/record.url?scp=85193443556&partnerID=8YFLogxK

المؤلفون: Coerver, E M E, Bourass, A, Wessels, M H J, van Kempen, Z L E, Jasperse, M M S, Tonino, B A R, Barkhof, F, Mostert, J, Uitdehaag, B M J, Killestein, J, Strijbis, E M M

المصدر: Coerver , E M E , Bourass , A , Wessels , M H J , van Kempen , Z L E , Jasperse , M M S , Tonino , B A R , Barkhof , F , Mostert , J , Uitdehaag , B M J , Killestein , J & Strijbis , E M M 2023 , ' Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis ' , Multiple Sclerosis and Related Disorders , vol. 74 , 104706 . https://doi.org/10.1016/j.msard.2023.104706

الاتاحة: https://research.vumc.nl/en/publications/6934b4a4-1e47-4962-b6dc-3a57e7ffca64
https://doi.org/10.1016/j.msard.2023.104706
http://www.scopus.com/inward/record.url?scp=85152289051&partnerID=8YFLogxK

المؤلفون: Toorop, A. A., Wessels, M. H.J., Gelissen, L. M.Y., Hoitsma, E., Zeinstra, E. M.P.E., van Rooij, L. C., van Munster, C. E.P., Vennegoor, A., Mostert, J. P., Wokke, B. H.A., Kalkers, N. F., Hoogervorst, E. L.J., van Eijk, J. J.J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L. G.F., Kloosterziel, M. E., Arnoldus, E. P.J., van Dijk, G. W., Bouvy, W. H., Strijbis, E. M.M., van Oosten, B. W., de Jong, B. A., Lissenberg-Witte, B. I., Rispens, T., Uitdehaag, B. M.J., Killestein, J., van Kempen, Z. L.E.

المصدر: Toorop , A A , Wessels , M H J , Gelissen , L M Y , Hoitsma , E , Zeinstra , E M P E , van Rooij , L C , van Munster , C E P , Vennegoor , A , Mostert , J P , Wokke , B H A , Kalkers , N F , Hoogervorst , E L J , van Eijk , J J J , Roosendaal , C M , Kragt , J J , Eurelings , M , van Genugten , J , Nielsen , J , Sinnige , L G F , Kloosterziel , M E , Arnoldus , E P J , van Dijk , G W , Bouvy , W H , Strijbis , E M M , van Oosten , B W , de Jong , B A , Lissenberg-Witte , B I , Rispens , T , Uitdehaag , B M J , Killestein , J & van Kempen , Z L E 2024 , ' Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial ' , Journal of the Neurological Sciences , vol. 462 , 123102 .

مصطلحات الفهرس: article

URL: https://pure.eur.nl/en/publications/0a5b3066-a6a8-4c03-b986-4f4eeb0a1f3f

المؤلفون: Boekel, L., Stalman, E., Wieske, L., Hooijberg, F., Besten, Y., Leeuw, M., Atiqi, S., Kummer, L., van Dam, K., Steenhuis, M., van Kempen, Z., Killestein, J., Lems, W., Tas, S., van Vollenhoven, R., Nurmohamed, M., Boers, M., van Ham, M., Rispens, T., Kuijpers, T., Eftimov, F., Wolbink, G.J.

المصدر: Annals of the Rheumatic Diseases ; volume 81, page 118 ; ISSN 0003-4967

الاتاحة: https://doi.org/10.1136/annrheumdis-2022-eular.4704
https://api.elsevier.com/content/article/PII:S0003496724267182?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0003496724267182?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.4704

المؤلفون: Kummer, L., Wieske, L., Stalman, E., Van Dam, K., Boekel, L., Wolbink, G., Volkers, A., Steenhuis, M., Verstegen, N., Rispens, T., Ten Brinke, A., Van Kempen, Z., Tas, S., Van Ham, M., Kuijpers, T., Eftimov, F.

المصدر: Annals of the Rheumatic Diseases ; volume 81, page 963 ; ISSN 0003-4967

الاتاحة: https://doi.org/10.1136/annrheumdis-2022-eular.3736
https://api.elsevier.com/content/article/PII:S0003496724281073?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0003496724281073?httpAccept=text/plain
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.3736

المؤلفون: Toorop, A A, van Lierop, Z Y G J, Strijbis, E M M, Teunissen, C E, Barkhof, F, Uitdehaag, B M J, van Kempen, Z L E, Killestein, J

المصدر: Toorop , A A , van Lierop , Z Y G J , Strijbis , E M M , Teunissen , C E , Barkhof , F , Uitdehaag , B M J , van Kempen , Z L E & Killestein , J 2022 , ' The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis ' , Multiple Sclerosis and Related Disorders , vol. 57 , 103364 , pp. 103364 . https://doi.org/10.1016/j.msard.2021.103364

الاتاحة: https://research.vumc.nl/en/publications/2f421c35-2497-4704-bdd2-77058e63b4f0
https://doi.org/10.1016/j.msard.2021.103364
http://www.scopus.com/inward/record.url?scp=85118876256&partnerID=8YFLogxK

المؤلفون: Volkers, A, Wieske, L, van Dam, K, Steenhuis, M, Stalman, E, Kummer, L, van Kempen, Z, Killestein, J, Tas, S, Boekel, L, Wolbink, G, Takkenberg, B, Spuls, P, Bosma, A, Rutgers, B, Verschuuren, J, van Ouwerkerk, L, van der Woude, D, van Paassen, P, Busch, M, Brusse, E, Hijnen, D, ten Brinke, A, Verstegen, N, D’Haens, G, van Ham, M, Kuijpers, T, Rispens, T, Löwenberg, M, Eftimov, F

المصدر: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i079-i079 ; ISSN 1873-9946 1876-4479

مصطلحات موضوعية: Gastroenterology, General Medicine

الاتاحة: http://dx.doi.org/10.1093/ecco-jcc/jjab232.066
https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i079/42250239/jjab232.066.pdf

المؤلفون: Coerver, E M E, Wessels, M H J, van Lierop, Z Y G, van Kempen, Z L E, Killestein, J, Strijbis, E M M

المصدر: Coerver , E M E , Wessels , M H J , van Lierop , Z Y G , van Kempen , Z L E , Killestein , J & Strijbis , E M M 2021 , ' Natalizumab discontinuation in a Dutch real-world cohort ' , Multiple Sclerosis and Related Disorders , vol. 52 , 102974 , pp. 102974 . https://doi.org/10.1016/j.msard.2021.102974 , https://doi.org/10.1016/j.msard.2021.102974

الاتاحة: https://research.vumc.nl/en/publications/4d926165-34a6-4055-b395-4ddf894f7b0e
https://doi.org/10.1016/j.msard.2021.102974
http://www.scopus.com/inward/record.url?scp=85105715255&partnerID=8YFLogxK

المؤلفون: van Lierop, Z. Y. G. J., Toorop, A. A., Coerver, E. M. E., Willemse, E. A. J., Strijbis, E. M. M., Kalkers, N. F., Moraal, B., Barkhof, F., Teunissen, C. E., Killestein, J., van Kempen, Z. L. E.

المصدر: van Lierop , Z Y G J , Toorop , A A , Coerver , E M E , Willemse , E A J , Strijbis , E M M , Kalkers , N F , Moraal , B , Barkhof , F , Teunissen , C E , Killestein , J & van Kempen , Z L E 2021 , ' Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients ' , Multiple sclerosis journal - experimental, translational and clinical , vol. 7 , no. 2 . https://doi.org/10.1177/20552173211013831

الاتاحة: https://research.vumc.nl/en/publications/645c9b0f-196b-4522-83bf-1a6829abf9a2
https://doi.org/10.1177/20552173211013831
http://www.scopus.com/inward/record.url?scp=85107232592&partnerID=8YFLogxK

المؤلفون: Volkers, A., Wieske, L., van Dam, K., Steenhuis, M., Stalman, E., Kummer, L., van Kempen, Z., Killestein, J., Tas, S., Boekel, L., Wolbink, G., Takkenberg, B., Spuls, P., Bosma, A., Rutgers, B., Verschuuren, J., van Ouwerkerk, L., van der Woude, D., van Paassen, P., Busch, M., Brusse, E., Hijnen, D., ten Brinke, A., Verstegen, N., D'Haens, G., van Ham, M., Kuijpers, T., Rispens, T., Lowenberg, M., Eftimov, F.

المصدر: Volkers , A , Wieske , L , van Dam , K , Steenhuis , M , Stalman , E , Kummer , L , van Kempen , Z , Killestein , J , Tas , S , Boekel , L , Wolbink , G , Takkenberg , B , Spuls , P , Bosma , A , Rutgers , B , Verschuuren , J , van Ouwerkerk , L , van der Woude , D , van Paassen , P , Busch , M , Brusse , E , Hijnen , D , ten Brinke , A , ....

مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

الاتاحة: https://pure.eur.nl/en/publications/9268c1bc-95d8-4fac-927a-3a6b7709f569
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000778573400068&DestLinkType=FullRecord&DestApp=WOS

المؤلفون: van ‘t Hullenaar, C. A. A., Coerver, E., Kalkers, N. F., van Kempen, Z., Koch, M., Uitdehaag, B. M. J., Killestein, J., Strijbis, E. M. M.

المصدر: van ‘t Hullenaar , C A A , Coerver , E , Kalkers , N F , van Kempen , Z , Koch , M , Uitdehaag , B M J , Killestein , J & Strijbis , E M M 2021 , ' The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis ' , Multiple Sclerosis and Related Disorders , vol. 55 , 103165 . https://doi.org/10.1016/j.msard.2021.103165

Relation: https://research.vumc.nl/en/publications/91042310-cc76-4d89-bc53-cbdf51c51d67

الاتاحة: https://research.vumc.nl/en/publications/91042310-cc76-4d89-bc53-cbdf51c51d67
https://doi.org/10.1016/j.msard.2021.103165
http://www.scopus.com/inward/record.url?scp=85112769715&partnerID=8YFLogxK

المؤلفون: Toorop, A. A., van Lierop, Z. Y. G. J., Strijbis, E. M. M., Teunissen, C. E., Barkhof, F., Uitdehaag, B. M. J., van Kempen, Z. L. E., Killestein, J.

المصدر: Toorop , A A , van Lierop , Z Y G J , Strijbis , E M M , Teunissen , C E , Barkhof , F , Uitdehaag , B M J , van Kempen , Z L E & Killestein , J 2021 , ' The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis ' , Multiple Sclerosis and Related Disorders . https://doi.org/10.1016/j.msard.2021.103364

مصطلحات موضوعية: psy, socio

Relation: https://research.vumc.nl/en/publications/1302d898-5eab-4adb-8584-c60d93d52d27

الاتاحة: https://research.vumc.nl/en/publications/1302d898-5eab-4adb-8584-c60d93d52d27

المؤلفون: Loonstra, F. C., Verberk, I. M. W., Wijburg, M. T., Wattjes, M. P., Teunissen, C. E., van Oosten, B. W., Uitdehaag, B. M. J., Killestein, J., van Kempen, Z. L. E.

المساهمون: Neurology, Clinical chemistry, Other Research, Amsterdam Neuroscience - Neuroinfection & -inflammation, Amsterdam Neuroscience - Neurodegeneration, AII - Inflammatory diseases

المصدر: Loonstra, F C, Verberk, I M W, Wijburg, M T, Wattjes, M P, Teunissen, C E, van Oosten, B W, Uitdehaag, B M J, Killestein, J & van Kempen, Z L E 2019, ' Serum neurofilaments as candidate biomarkers of natalizumab-associated PML ', Multiple Sclerosis Journal, vol. 25, pp. 284-284 .
Multiple Sclerosis Journal, 25, 284-284. SAGE Publications

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9e7d0b63bbb9e9b3805c6968aa324366
https://research.vumc.nl/en/publications/f39f374a-4126-4fd8-93e0-3d6640707a7b

المؤلفون: Loonstra, F. C., van Rossum, J. A., van Kempen, Z. L. E., Rispens, T., Uitdehaag, B. M. J., Killestein, J.

المساهمون: Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, AII - Inflammatory diseases

المصدر: Multiple Sclerosis Journal, 25, 26-26. SAGE Publications
Loonstra, F C, van Rossum, J A, van Kempen, Z L E, Rispens, T, Uitdehaag, B M J & Killestein, J 2019, ' Infusion-related events during natalizumab: no need for post-infusion monitoring ', Multiple Sclerosis Journal, vol. 25, pp. 26-26 .

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9b9a58cd7acc65412ce1ad792ba401e4
https://research.vumc.nl/en/publications/d172b76e-d207-4063-9e6e-9596cdd951c6

المؤلفون: Dekker, I, Leurs, C E, Hagens, M H J, van Kempen, Z L E, Kleerekooper, I, Lissenberg-Witte, B I, Barkhof, F, Uitdehaag, B M J, Balk, L J, Wattjes, M P, Killestein, J

المصدر: Dekker , I , Leurs , C E , Hagens , M H J , van Kempen , Z L E , Kleerekooper , I , Lissenberg-Witte , B I , Barkhof , F , Uitdehaag , B M J , Balk , L J , Wattjes , M P & Killestein , J 2019 , ' Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab ' , Multiple Sclerosis and Related Disorders , vol. 33 , pp. 82-87 . https://doi.org/10.1016/j.msard.2019.05.017

Relation: https://research.vumc.nl/en/publications/170025e9-cbcb-41a2-af40-d1606d575fae

الاتاحة: https://research.vumc.nl/en/publications/170025e9-cbcb-41a2-af40-d1606d575fae
https://doi.org/10.1016/j.msard.2019.05.017
http://www.scopus.com/inward/record.url?scp=85066434679&partnerID=8YFLogxK

المؤلفون: van Kempen, Z. L.E., Leurs, C. E., de Vries, A., Vennegoor, A., Rispens, T., Wattjes, M. P., Killestein, J.

المصدر: van Kempen , Z L E , Leurs , C E , de Vries , A , Vennegoor , A , Rispens , T , Wattjes , M P & Killestein , J 2017 , ' John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients ' , European Journal of Neurology , vol. 24 , no. 9 , pp. 1196-1199 . https://doi.org/10.1111/ene.13355

الاتاحة: https://research.vumc.nl/en/publications/23b28680-9afb-4e79-b9c8-68e49d4188c6
https://doi.org/10.1111/ene.13355
http://www.scopus.com/inward/record.url?scp=85023646437&partnerID=8YFLogxK

المؤلفون: van 't Hullenaar, C.A.A., Coerver, E., Kalkers, N.F., van Kempen, Z., Koch, M., Uitdehaag, B.M.J., Killestein, J., Strijbis, E.M.M.

المصدر: Multiple Sclerosis & Related Disorders; Oct2021, Vol. 55, pN.PAG-N.PAG, 1p